Next Article in Journal
Polycyclic Aromatic Hydrocarbons in Maternal and Umbilical Cord Blood from Pregnant Hispanic Women Living in Brownsville, Texas
Next Article in Special Issue
Alcohol Policy, Social Context, and Infant Health: The Impact of Minimum Legal Drinking Age
Previous Article in Journal
Street Connectivity is Negatively Associated with Physical Activity in Canadian Youth
Previous Article in Special Issue
Increasing and Decreasing Alcohol Use Trajectories Among Older Women in the U.S. Across a 10-Year Interval
Article Menu

Export Article

Open AccessReview
Int. J. Environ. Res. Public Health 2011, 8(8), 3351-3364;

A Literature Review of Cost-Benefit Analyses for the Treatment of Alcohol Dependence

Social and Epidemiological Research Department, Centre for Addiction and Mental Health, 33 Russell St., Toronto, Ontario M5S 2S1, Canada
Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario M5T 3M7, Canada
Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor St. West, Toronto, Ontario M5S 1V4, Canada
Eli Lilly and Company, Global Health Outcomes, Indianapolis, IN 46285, USA
Klinische Psychologie und Psychotherapie, Epidemiological Research Unit, Technische Universität, Hohe Street 53, Dresden D-01187, Germany
Author to whom correspondence should be addressed.
Received: 7 June 2011 / Revised: 3 August 2011 / Accepted: 3 August 2011 / Published: 16 August 2011
(This article belongs to the Special Issue Alcohol and Public Health)
Full-Text   |   PDF [224 KB, uploaded 19 June 2014]


The purpose of this study was to conduct a literature review of cost-benefit studies on pharmacotherapy and psychotherapy treatments of alcohol dependence (AD). A literature search was performed in multiple electronic bibliographic databases. The search identified seven psychotherapy studies from the USA and two pharmacotherapy studies from Europe. In the psychotherapy studies, major benefits are typically seen within the first six months of treatment. The benefit-cost ratio ranged from 1.89 to 39.0. Treatment with acamprosate was found to accrue a net benefit of 21,301 BEF (528 €) per patient over a 24-month period in Belgium and lifetime benefit for each patient in Spain was estimated to be Pta. 3,914,680 (23,528 €). To date, only a few studies exist that have examined the cost-benefit of psychotherapy or pharmacotherapy treatment of AD. Most of the available treatment options for AD appear to produce marked economic benefits. View Full-Text
Keywords: alcohol dependence treatment; psychotherapy; pharmacotherapy; costs; benefits alcohol dependence treatment; psychotherapy; pharmacotherapy; costs; benefits
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Popova, S.; Mohapatra, S.; Patra, J.; Duhig, A.; Rehm, J. A Literature Review of Cost-Benefit Analyses for the Treatment of Alcohol Dependence. Int. J. Environ. Res. Public Health 2011, 8, 3351-3364.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top